ICARISIDE II
공식 표시명·정의
JCIA 표시명 イカリシドⅡ: 本品は、次の化学式で表される有機化合物である。
별칭·식별 정보
ICARISIDE IIINCIICARISIDE II동의어
- cas
- 113558-15-9
- dtxsid
- DTXSID40150457
- dtxcid
- DTXCID4072948
- IUPAC
- 5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-1-benzopyran-3-yl 6-deoxy-alpha-L-mannopyranoside
- 분자식
- C27H30O10
- 분자량
- 514.527 g/mol
화장품에서 하는 역할
BLEACHINGSKIN CONDITIONING - EMOLLIENTSKIN PROTECTINGSKIN CONDITIONINGANTIOXIDANT
안전·규제 요약
Other restriction: ban substances that deplete the ozone layer
연결된 공식 원본 데이터
관련 문헌
- Xianling Lianxia formula enhances the inhibitory effects of trastuzumab on HER2-positive breast cancer · 2023
- Epimedium brevicornum Maxim. Extract exhibits pigmentation by melanin biosynthesis and melanosome biogenesis/transfer · 2022
- Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF. · 2020
- Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells. · 2014
- Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells. · 2013